Thomas M. Ross - 02 Dec 2022 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
02 Dec 2022
Net transactions value
-$137,840
Form type
4
Filing time
06 Dec 2022, 16:31:47 UTC
Previous filing
03 Nov 2022
Next filing
05 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $16,200 +15,000 $1.08 15,000 02 Dec 2022 Direct F1, F2
transaction MXCT Common Stock Sale $90,300 -15,000 -100% $6.02 0 02 Dec 2022 Direct F1, F3
transaction MXCT Common Stock Options Exercise $15,264 +14,133 $1.08 14,133 05 Dec 2022 Direct F1, F2
transaction MXCT Common Stock Sale $79,003 -14,133 -100% $5.59 0 05 Dec 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -15,000 -25% $0.000000 45,734 02 Dec 2022 Common Stock 15,000 $1.08 Direct F1, F2, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -14,133 -31% $0.000000 31,601 05 Dec 2022 Common Stock 14,133 $1.08 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022.
F2 This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.00 to $6.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.35 to $5.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5 This option is fully vested and exercisable.